Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $429.0000 (-1.22%) ($426.4000 - $438.4700) on Fri. May. 5, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.94% (three month average) | RSI | 75 | Latest Price | $429.0000(-1.22%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 2% a day on average for past five trading days. | Weekly Trend | REGN advances 6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(61%) XLV(49%) XBI(44%) IVW(42%) QQQ(42%) | Factors Impacting REGN price | REGN will decline at least -0.97% in a week (0% probabilities). UUP(-9%) VIXM(-8%) TLT(-6%) TIP(-2%) SHY(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.97% (StdDev 1.94%) | Hourly BBV | 0 () | Intraday Trend | -1.3% | | | |
|
5 Day Moving Average | $413.71(3.7%) | 10 Day Moving Average | $395.29(8.53%) | 20 Day Moving Average | $383.64(11.82%) | To recent high | -1.2% | To recent low | 21.4% | Market Cap | $45.486b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |